Stress and Drug-Cue-Induced Craving in Opioid-Dependent Individuals in Naltrexone Treatment

Experimental and Clinical Psychopharmacology

Volumn 15, Issue 2, 2007, Pages 134-143

  Hyman, Scott M ^a   Fox, Helen ^a   Hong, Kwang Ik A ^a   Doebrick, Cheryl ^a   Sinha, Rajita ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

drug cue; naltrexone; opioid craving; opioid dependence; stress

Indexed keywords

NALTREXONE; NARCOTIC ANTAGONIST;

ADULT; ANXIETY; AROUSAL; ARTICLE; ASSOCIATION; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; EMOTION; FEMALE; HEART RATE; HUMAN; IMAGERY; MALE; OPIATE ADDICTION; STRESS; SYSTOLIC BLOOD PRESSURE; WITHDRAWAL SYNDROME; ADDICTION; BLOOD PRESSURE; CLINICAL TRIAL; DRUG EFFECT; MENTAL STRESS; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY;

ADULT; ANXIETY; BEHAVIOR, ADDICTIVE; BLOOD PRESSURE; CUES; EMOTIONS; FEMALE; HEART RATE; HUMANS; IMAGERY (PSYCHOTHERAPY); MALE; NALTREXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; STRESS, PSYCHOLOGICAL;

EID: 34250803880     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.15.2.134     Document Type: Article

References (56)

1. Alderson H.L., Robbins T.W., and Everitt B.J. Heroin self-administration under a second-order schedule of reinforcement: Acquisition and maintenance of heroin-seeking behaviour in rats. Psychopharmacology (Berl) 153 (2000) 120-133
2. Aston-Jones G., and Harris G.C. Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47 Suppl. 1 (2004) 167-179
3. Bradley B.P., Phillips G., Green L., and Gossop M. Circumstances surrounding the initial relapse to opiate use following detoxification. British Journal of Psychiatry 154 (1989) 354-359
4. Brady K.T., Back S.E., Waldrop A.E., McRae A.L., Anton R.F., Upadhyaya H.P., et al. Cold pressor task reactivity: Predictors of alcohol use among alcohol-dependent individuals with and without comorbid posttraumatic stress disorder. Alcoholism: Clinical and Experimental Research 30 (2006) 938-946
5. Breese G.R., Chu K., Dayas C.V., Funk D., Knapp D.J., Koob G.F., et al. Stress enhancement of craving during sobriety: A risk for relapse. Alcoholism: Clinical and Experimental Research 29 (2005) 185-195
6. Brown R. Heroin dependence. Wisconsin Medical Journal 103 4 (2004) 20-26
7. Carlson L.E., Ursuliak Z., Goodey E., Angen M., and Speca M. The effects of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients: 6-month follow-up. Supportive Care in Cancer 9 (2001) 112-123
8. Carroll K.M., Sinha R., Nich C., Babuscio T., and Rounsaville B.J. Contingency management to enhance naltrexone treatment of opioid dependence: A randomized clinical trial of reinforcement magnitude. Experimental and Clinical Psychopharmacology 10 (2002) 54-63
9. Childress A.R., Ehrman R., McLellan T., MacRae J., Natale M., and O'Brien C.P. Can induced moods trigger drug-related responses in opiate abuse patients?. Journal of Substance Abuse Treatment 11 (1994) 17-23
10. Cooney N.L., Litt M.D., Morse P.A., Bauer L.O., and Gaupp L. Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. Journal of Abnormal Psychology 106 (1997) 243-250
11. Do Couto B.R., Aguilar M.A., Manzanedo C., Rodriguez-Arias M., Armario A., and Minarro J. Social stress is as effective as physical stress in reinstating morphine-induced place preference in mice. Psychopharmacology (Berl) 185 (2006) 459-470
12. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I disorders-Patient edition (SCID-I/P, Version 2.0) (1997), New York State Psychiatric Institute, New York
13. Franken I.H.A., De Hann H.A., Van Der Meer C.W., Haffmans P.M.J., and Hendriks V.M. Cue reactivity and effects of cue exposure in abstinent posttreatment drug users. Journal of Substance Abuse Treatment 16 (1999) 81-85
14. Gerra G., Zaimovic A., Giusti F., Di Gennaro C., Zambelli U., Gardini S., and Delsignore R. Lofexidine versus clonidine in rapid opiate detoxification. Journal of Substance Abuse Treatment 21 (2001) 11-17
15. Goeders N.E. The impact of stress on addiction. European Neuropsychopharmacology 13 (2003) 435-441
16. Hays K.F. Working it out: Using exercise in psychotherapy (1999), American Psychological Association, Washington, DC
17. Highfield D., Yap J., Grimm J.W., Shalev U., and Shaham Y. Repeated lofexidine treatment attenuates stress-induced, but not drug cues-induced reinstatement of a heroin-cocaine mixture (speedball) seeking in rats. Neuropsychopharmacology 25 (2001) 320-331
18. Izard C. Patterns of emotions: A new analysis of anxiety and depression (1972), Academic Press, New York
19. Kabat-Zinn J., Massion A.O., Kristeller J., Peterson L.G., Fletcher K.E., Pbert L., et al. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. American Journal of Psychiatry 149 (1992) 936-943
20. Killian A.K., Bonese K., and Schuster C.R. The effects of naloxone on behavior maintained by cocaine and heroin injections in the rhesus monkey. Drug and Alcohol Dependence 3 (1978) 243-251
21. Kirchmayer U., Davoli M., Verster A.D., Amato L., Ferri M., and Perucci C.A. A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence. Addiction 97 (2002) 1241-1249
22. Klein L.C., Jamner L.D., Alberts J., Ornstein M.D., and Leigh H. Sex differences in salivary cortisol levels following naltrexone administration. Journal of Applied Biobehavioral Research 5 (2000) 144-153
23. Kosten T.R., Kreek M.J., Ragunath J., and Kleber H.D. Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts. Biological Psychiatry 21 (1986) 217-220
24. Landsberg R., Taintor Z., Plumb M., Amico L., and Wicks N. An analysis of naltrexone use: Its efficacy, safety and potential. National Institute on Drug Abuse Research Monograph 9 (1976) 106-113
25. Le A.D., Harding S., Juzytsch W., Watchus J., Shalev U., and Shaham Y. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl) 150 (2000) 317-324
26. Lehrer P.M. Varieties of relaxation methods and their unique effects. International Journal of Stress Management 3 (1996) 1-15
27. Leri F., Flores J., Rodaros D., and Stewart J. Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. Journal of Neuroscience 22 (2002) 5713-5718
28. Leri F., Tremblay A., Sorge R.E., and Stewart J. Methadone maintenance reduces heroin- and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of poly-drug use. Neuropsychopharmacology 29 (2004) 1312-1320
29. Lin S.K., Strang J., Su L.W., Tsai C.J., and Hu W.H. Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal. Drug and Alcohol Dependence 48 (1997) 127-133
30. Littell R., Milliken G., Strout W., and Wolfinger R. SAS systems for mixed models (1996), SAS Institute, Cary, NC
31. Liu X., and Weiss F. Additive effect of stress and drug cues on reinstatement of ethanol seeking: Exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. Journal of Neuroscience 22 (2002) 7856-7861
32. Marlatt A.G. Buddhist philosophy and the treatment of addictive behavior. Cognitive and Behavioral Practice 9 (2002) 44-50
33. McCubbin J.A., Bruehl S., Wilson J.F., Sherman J.J., Norton J.A., and Colclough G. Endogenous opioids inhibit ambulatory blood pressure during naturally occurring stress. Psychosomatic Medicine 60 (1998) 227-231
34. Meichenbaum D. Stress inoculation training (1985), Pergamon Press, New York
35. Mello N.K., and Negus S.S. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14 (1996) 375-424
36. National Center on Addiction and Substance Abuse at Columbia University. Under the counter: The diversion and abuse of controlled prescription drugs in the U.S (2005, July), Author, New York
37. Powell J., Bradley B., and Gray J. Classical conditioning and cognitive determinants of subjective craving for opiates: An investigation of their relative contributions. British Journal of Addiction 87 (1992) 1133-1144
38. Rosenzweig S., Reibel D.K., Greeson J.M., Brainard G.C., and Hojat M. Mindfulness-based stress reduction lowers psychological distress in medical students. Teaching and Learning in Medicine 15 (2003) 88-92
39. Rounsaville B.J. Can psychotherapy rescue naltrexone treatment of opioid addiction?. In: Onken L.S., and Blaine J.D. (Eds). Potentiating the efficacy of medications: Integrating psychosocial therapies with pharmacotherapies in the treatment of drug dependence. (NIDA Research Monograph Series No. 105, NIH Publication No. 95-3899) (1995), National Institute on Drug Abuse, Rockville, MD 37-52
40. Shaham Y., Erb S., Leung S., Buczek Y., and Stewart J. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor type 1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology (Berl) 137 (1998) 184-190
41. Shaham Y., Funk D., Erb S., Brown T.J., Walker C.D., and Stewart J. Corticosterone does not contribute to relapse to heroin seeking in rats induced by footshock stress or priming injections of heroin. Journal of Neuroscience 17 (1997) 2605-2614
42. Shaham Y., Highfield D., Delfs J., Leung S., and Stewart J. Clonidine blocks stress-induced reinstatement of heroin seeking in rats: An effect independent of locus coeruleus noradrenergic neurons. European Journal of Neuroscience 12 (2000) 292-302
43. Shaham Y., and Stewart J. Stress reinstates heroin-seeking in drug-free animals: An effect mimicking heroin, not withdrawal. Psychopharmacologia 119 (1995) 334-341
44. Shaham Y., and Stewart J. Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats. Psychopharmacology (Berl) 125 (1996) 385-391
45. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology (Berl) 158 (2001) 343-359
46. Sinha R., Catapano D., and O'Malley S. Stress-induced craving and stress response in cocaine dependent individuals. Psychopharmacology (Berl) 142 (1999) 343-351
47. Sinha R., Fuse T., Aubin L., and O'Malley S. Psychological stress, drug-related cues and cocaine craving. Psychopharmacology (Berl) 152 (2000) 140-148
48. Sinha R., Garcia M., Paliwal P., Kreek M.J., and Rounsaville B.J. Stress-induced cocaine craving and HPA responses predict cocaine relapse outcomes. Archives of General Psychiatry 63 (2006) 324-331
49. Sinha R., Talih M., Malison R., Cooney N., Anderson G.M., and Kreek M.J. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug-cue-induced cocaine craving states. Psychopharmacology (Berl) 170 (2003) 62-72
50. Sorge R.E., Rajabi H., and Stewart J. Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement. Neuropsychopharmacology 30 (2005) 1681-1692
51. Stewart J. Stress and relapse to drug seeking: Studies in laboratory animals shed light on mechanisms and sources of long-term vulnerability. American Journal on Addictions 12 (2003) 1-17
52. Tucker T.K., and Ritter A.J. Naltrexone in the treatment of heroin dependence: A literature review. Drug and Alcohol Review 19 (2000) 73-82
53. Uhart M., Chong R.Y., Oswald L., Lin P.I., and Wand G.S. Gender differences in hypothalamic-pituitary-adrenal (HPA) axis reactivity. Psychoneuroendocrinology 31 (2006) 642-652
54. Wallace B.C. Psychological and environmental determinants of relapse in crack cocaine smokers. Journal of Substance Abuse Treatment 6 (1989) 95-106
55. Weinstein A., Wilson S., Bailey J., Myles J., and Nutt D. Imagery of craving in opiate addicts undergoing detoxification. Drug and Alcohol Dependence 48 (1997) 25-31
56. Zacny J., Bigelow G., Compton P., Foley K., Iguchi M., and Sannerud C. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: Position statement. Drug and Alcohol Dependence 69 (2003) 215-232